Terms: = Germ cell tumor AND COX6C, P09669, 1345, ENSG00000164919
18 results:
1. A mature ovarian teratoma from New Kingdom Amarna, Egypt.
Dabbs GR; Stevens A; Wetzel MK
Int J Paleopathol; 2023 Dec; 43():99-105. PubMed ID: 37913592
[TBL] [Abstract] [Full Text] [Related]
2. The International Association for the Study of Lung Cancer Thymic Epithelial tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant tumors.
Fang W; Girard N; Cilento V; Goren E; Dibaba D; Ruffini E; Ahmad U; Appel S; Bille A; Boubia S; Brambilla C; Cangir AK; Detterbeck F; Falkson C; Filosso PL; Giaccone G; Guerrera F; Huang J; Infante M; Kim DK; Lucchi M; Marino M; Marom EM; Nicholson AG; Okumura M; Rami-Porta R; Rimner A; Simone CB; Asamura H;
J Thorac Oncol; 2024 Jan; 19(1):52-70. PubMed ID: 37774950
[TBL] [Abstract] [Full Text] [Related]
3. A practical solution to estimate the sample size required for clinical prediction models generated from observational research on data.
Baeza-Delgado C; Cerdá Alberich L; Carot-Sierra JM; Veiga-Canuto D; Martínez de Las Heras B; Raza B; Martí-Bonmatí L
Eur Radiol Exp; 2022 Jun; 6(1):22. PubMed ID: 35641659
[TBL] [Abstract] [Full Text] [Related]
4. Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab.
Bradu S; Siegel D; Loyal J; Leaf A; Kurtti A; Alapati U; Jagdeo J
J Drugs Dermatol; 2021 Dec; 20(12):1343-1345. PubMed ID: 34898148
[TBL] [Abstract] [Full Text] [Related]
5. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy.
Tapeinos C; Marino A; Battaglini M; Migliorin S; Brescia R; Scarpellini A; De Julián Fernández C; Prato M; Drago F; Ciofani G
Nanoscale; 2018 Dec; 11(1):72-88. PubMed ID: 30357214
[TBL] [Abstract] [Full Text] [Related]
6. Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
Dummer R; Ascierto PA; Gogas HJ; Arance A; Mandala M; Liszkay G; Garbe C; Schadendorf D; Krajsova I; Gutzmer R; Chiarion Sileni V; Dutriaux C; de Groot JWB; Yamazaki N; Loquai C; Moutouh-de Parseval LA; Pickard MD; Sandor V; Robert C; Flaherty KT
Lancet Oncol; 2018 Oct; 19(10):1315-1327. PubMed ID: 30219628
[TBL] [Abstract] [Full Text] [Related]
7. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Dreno B; Thompson JF; Smithers BM; Santinami M; Jouary T; Gutzmer R; Levchenko E; Rutkowski P; Grob JJ; Korovin S; Drucis K; Grange F; Machet L; Hersey P; Krajsova I; Testori A; Conry R; Guillot B; Kruit WHJ; Demidov L; Thompson JA; Bondarenko I; Jaroszek J; Puig S; Cinat G; Hauschild A; Goeman JJ; van Houwelingen HC; Ulloa-Montoya F; Callegaro A; Dizier B; Spiessens B; Debois M; Brichard VG; Louahed J; Therasse P; Debruyne C; Kirkwood JM
Lancet Oncol; 2018 Jul; 19(7):916-929. PubMed ID: 29908991
[TBL] [Abstract] [Full Text] [Related]
8. Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal: ORIGINAL ARTICLE: Wolchok JD, Chiarion-Sileni V, Gonzalez R et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 2017; 377:1345-56.
Wan MT; Ming ME
Br J Dermatol; 2018 Aug; 179(2):296-300. PubMed ID: 29766492
[TBL] [Abstract] [Full Text] [Related]
9. Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.
Dummer R; Ascierto PA; Gogas HJ; Arance A; Mandala M; Liszkay G; Garbe C; Schadendorf D; Krajsova I; Gutzmer R; Chiarion-Sileni V; Dutriaux C; de Groot JWB; Yamazaki N; Loquai C; Moutouh-de Parseval LA; Pickard MD; Sandor V; Robert C; Flaherty KT
Lancet Oncol; 2018 May; 19(5):603-615. PubMed ID: 29573941
[TBL] [Abstract] [Full Text] [Related]
10. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.
Miller CJ; Shin TM; Sobanko JF; Sharkey JM; Grunyk JW; Elenitsas R; Chu EY; Capell BC; Ming ME; Etzkorn JR
J Am Acad Dermatol; 2017 Aug; 77(2):333-340.e1. PubMed ID: 28711085
[TBL] [Abstract] [Full Text] [Related]
11. Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.
Rump A; Benet-Pages A; Schubert S; Kuhlmann JD; Janavičius R; Macháčková E; Foretová L; Kleibl Z; Lhota F; Zemankova P; Betcheva-Krajcir E; Mackenroth L; Hackmann K; Lehmann J; Nissen A; DiDonato N; Opitz R; Thiele H; Kast K; Wimberger P; Holinski-Feder E; Emmert S; Schröck E; Klink B
PLoS Genet; 2016 Aug; 12(8):e1006248. PubMed ID: 27504877
[TBL] [Abstract] [Full Text] [Related]
12. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract] [Full Text] [Related]
13. Expression of HERC4 in lung cancer and its correlation with clinicopathological parameters.
Zeng WL; Chen YW; Zhou H; Zhou JY; Wei M; Shi R
Asian Pac J Cancer Prev; 2015; 16(2):513-7. PubMed ID: 25684480
[TBL] [Abstract] [Full Text] [Related]
14. Intralabyrinthine schwannomas: imaging diagnosis and classification.
Salzman KL; Childs AM; Davidson HC; Kennedy RJ; Shelton C; Harnsberger HR
AJNR Am J Neuroradiol; 2012 Jan; 33(1):104-9. PubMed ID: 22158921
[TBL] [Abstract] [Full Text] [Related]
15. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
[TBL] [Abstract] [Full Text] [Related]
16. Uterine choriocarcinoma in a postmenopausal woman.
Mukherjee U; Thakur V; Katiyar D; Goyal HK; Pendharkar D
Med Oncol; 2006; 23(2):301-3. PubMed ID: 16720931
[TBL] [Abstract] [Full Text] [Related]
17. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract] [Full Text] [Related]
18. Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Schumacher T; Hofer S; Eichhorn K; Wasner M; Zimmerer S; Freitag P; Probst A; Gratzl O; Reubi JC; Maecke R; Mueller-Brand J; Merlo A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):486-93. PubMed ID: 11914886
[TBL] [Abstract] [Full Text] [Related]
